CES 2025: DeepSleep to Debut Scientifically Proven Technology that Improves Sleep Immediately without Medication

December 20, 2024 03:52 AM AEDT | By EIN Presswire
 CES 2025: DeepSleep to Debut Scientifically Proven Technology that Improves Sleep Immediately without Medication
Image source: EIN Presswire
AMSTERDAM, NETHERLANDS, December 19, 2024 /EINPresswire.com/ -- Deep Sleep Technologies, a deep science-based sleep technology startup and a spin-out of the University of Amsterdam, today announced it will debut its scientifically proven DeepSleep technology that improves both sleep onset and sleep duration almost immediately—without medication—at CES 2025.

Based on more than a decade of research in sleep and neuroscience, DeepSleep’s patented and proprietary method adapts to a sleeper’s unique brainwaves, gently enhancing their natural rhythm and creating a snowball effect of larger sleep waves.

DeepSleep’s founders and Dr. Gina Poe, neuroscientist, globally renowned sleep expert and member of the Scientific Advisory Board for DeepSleep Technologies, will showcase the company’s technology at CES in Eureka Park at the Venetian Exp (Hall G, Booth 62100) from January 7-10, 2025. Visitors can learn how the brain behaves during sleep by stepping into DeepSleep’s cubicle and experiencing an immersive 3D animation.

The world is faced with a global sleep crisis. According to recent findings from the CDC, 33% of U.S. adults and children (under 14) and 75% of high school teenagers do not get enough sleep. Insufficient sleep can cause significant adverse health effects — including increased risk of anxiety, depression, obesity, heart disease, injury, all-cause mortality and neurological disorders. Thirty-three million Americans use sleep medications to fall asleep every night, but sleeping pills can come with significant side effects.

Further, in a recent study, the costs associated with insufficient sleep in 2020 for the U.S. range between $299 billion to $433 billion. However, this will increase by 2030, when the range is between $318 to $456 billion. DeepSleep was founded on the belief that the world needs a non-invasive and side-effect-free solution to what the WHO calls a sleep loss epidemic.

“Sufficient sleep is one of the most important factors for overall good health,” said Dr. Lucia Talamini, co-founder of DeepSleep Technologies. “Our non-invasive technology improves sleep by gently stimulating and modulating a user’s brain waves during sleep. We look forward to partnering with companies passionate about solving the global sleep crisis by integrating our technology into their products.”

DeepSleep continuously monitors and predicts brain activity and new predictions are made in less than two milliseconds. In doing so, DeepSleep can forecast deep sleep waves and stimulate the brain with a non-invasive sonic pulse at the ideal moment to deepen sleep waves, improving sleep quality, depth and brain wave clearing.

In sleep studies of DeepSleep’s technology, 64% of trial participants reported improved sleep quality, and 78% reported decreased daytime sleepiness. Extensive studies conducted at DeepSleep’s sleep clinics have shown that the method works to improve sleep in users with PTSD and those suffering from sleep disruption through environmental noise pollution. DeepSleep Technologies aims to partner with consumer and enterprise brands that want to incorporate its revolutionary sleep technology into existing or new products.

“Dr. Talamini is a well-respected sleep researcher with decades of experience in human sleep signatures and their optimization. Her research is rigorous. We have put our heads together, talking about the features of sleep for learning, memory and cognition,” said Poe. “I am convinced that the DeepSleep approach is fully informed by cutting-edge basic and clinical research and is the most effective system on the market today for achieving optimal deep sleep."

Contact [email protected] to set up a meeting at CES 2025 between January 7-10 in Las Vegas or learn more at https://www.fordeepsleep.com.

About DeepSleep

DeepSleep Technologies uses science-backed methodologies to improve people’s sleep without medication or complicated routines. The technology easily integrates with existing consumer and enterprise technology and stimulates brain waves to improve the quality and duration of a user’s sleep. DeepSleep’s technology is based on more than 12 years of research by Dr. Lucia Talamini, PhD, a leading neuroscientist studying memory and sleep.

Founded in 2024 and headquartered in Amsterdam, DeepSleep Technologies is a privately held company. Follow DeepSleep Technologies on LinkedIn or learn more at www.fordeepsleep.com.

Mindy M. Hull
Mercury Global Partners for DeepSleep
+1 415-889-9977
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.